HealthEquity, Inc. $HQY Stake Lessened by Greenhouse Funds LLLP

Key Points

• Greenhouse Funds LLLP reduced its stake in HealthEquity, Inc. by 13.5%, holding approximately 765,185 shares after selling 119,219 shares in the first quarter.
• HealthEquity's stock opened at $95.54 and experienced a 7.5% increase, contributing to a market capitalization of $8.26 billion.
• The company reported $0.97 EPS for the quarter, surpassing estimates, and a revenue of $330.80 million compared to a forecast of $322.25 million.

Greenhouse Funds LLLP cut its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 13.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 765,185 shares of the company's stock after selling 119,219 shares during the period. HealthEquity makes up approximately 3.2% of Greenhouse Funds LLLP's investment portfolio, making the stock its 15th biggest position. Greenhouse Funds LLLP owned approximately 0.88% of HealthEquity worth $67,619,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Versant Capital Management Inc bought a new stake in HealthEquity during the first quarter worth approximately $28,000. WPG Advisers LLC bought a new stake in HealthEquity during the first quarter worth approximately $28,000. Northwestern Mutual Wealth Management Co. boosted its holdings in HealthEquity by 176.4% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company's stock worth $58,000 after buying an additional 418 shares in the last quarter. Larson Financial Group LLC lifted its position in shares of HealthEquity by 1,366.0% in the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company's stock valued at $61,000 after acquiring an additional 642 shares in the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S purchased a new stake in shares of HealthEquity in the 1st quarter valued at approximately $65,000. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Stock Up 7.5%

HealthEquity stock opened at $95.54 on Thursday. The company has a market capitalization of $8.26 billion, a P/E ratio of 69.74, a P/E/G ratio of 1.38 and a beta of 0.50. The firm's fifty day simple moving average is $94.78 and its 200-day simple moving average is $95.36. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50. HealthEquity, Inc. has a 1-year low of $73.84 and a 1-year high of $116.65.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.81 by $0.16. The firm had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. During the same quarter last year, the firm posted $0.80 EPS. Sell-side analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Jon Kessler sold 134,183 shares of HealthEquity stock in a transaction on Friday, June 6th. The shares were sold at an average price of $112.08, for a total value of $15,039,230.64. Following the transaction, the director owned 253,510 shares in the company, valued at $28,413,400.80. This trade represents a 34.61% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Elimelech Rosner sold 58,000 shares of the firm's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the completion of the sale, the executive vice president owned 75,689 shares in the company, valued at $8,519,553.84. This represents a 43.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 291,744 shares of company stock worth $32,705,007 in the last quarter. 1.50% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research firms have issued reports on HQY. Jefferies Financial Group increased their target price on shares of HealthEquity from $130.00 to $134.00 and gave the stock a "buy" rating in a research report on Wednesday. Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. Barrington Research reiterated an "outperform" rating and issued a $125.00 target price on shares of HealthEquity in a research report on Friday, August 29th. JPMorgan Chase & Co. increased their target price on shares of HealthEquity from $125.00 to $126.00 and gave the stock an "overweight" rating in a research report on Wednesday. Finally, JMP Securities increased their target price on shares of HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research report on Wednesday, June 4th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, HealthEquity currently has an average rating of "Buy" and a consensus price target of $119.77.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.